According to OSE Immunotherapeutics's latest financial reports the company's current revenue (TTM ) is โฌ2.69 Million. In 2025 the company made a revenue of โฌ2.61 Million a decrease over the revenue in the year 2024 that were of โฌ69.87 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.